Header cover image

Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedJun 04, 2025
DataAggregated Company Financials
Companies11
  • 7D-0.5%
  • 3M11.6%
  • 1Y47.9%
  • YTD24.1%

Over the last 7 days, the Pharma industry has remained flat, although notably Sabaa International Company for Pharmaceutical and Chemical Industry gained 26%. The past year has been better, since the industry has gained 48% in that time. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 04 Jun 2025ج.م30.0bج.م28.0bج.م2.8b7x10.9x1.1x
Fri, 02 May 2025ج.م29.5bج.م26.2bج.م2.8b8.1x10.5x1.1x
Sun, 30 Mar 2025ج.م28.3bج.م26.2bج.م2.8b7.5x10.1x1.1x
Tue, 25 Feb 2025ج.م26.0bج.م24.8bج.م2.7b6.5x9.6x1x
Thu, 23 Jan 2025ج.م24.1bج.م23.7bج.م2.4b9.1x10.1x1x
Sat, 21 Dec 2024ج.م23.8bج.م23.7bج.م2.4b9x10x1x
Mon, 18 Nov 2024ج.م24.1bج.م23.2bج.م2.4b7x10.2x1x
Wed, 16 Oct 2024ج.م24.1bج.م22.1bج.م2.1b6.9x11.2x1.1x
Fri, 13 Sep 2024ج.م19.8bج.م22.2bج.م2.3b5.5x8.7x0.9x
Sun, 11 Aug 2024ج.م18.7bج.م21.3bج.م2.5b5.2x7.6x0.9x
Tue, 09 Jul 2024ج.م18.8bج.م21.3bج.م2.5b5x7.7x0.9x
Thu, 06 Jun 2024ج.م18.6bج.م20.6bج.م2.0b7x9.4x0.9x
Sat, 04 May 2024ج.م18.5bج.م19.8bج.م1.9b7.8x9.9x0.9x
Mon, 01 Apr 2024ج.م21.6bج.م19.4bج.م2.3b8x9.6x1.1x
Wed, 28 Feb 2024ج.م24.4bج.م18.5bج.م2.4b9.8x10.2x1.3x
Fri, 26 Jan 2024ج.م19.6bج.م18.5bج.م2.4b7.9x8.2x1.1x
Sun, 24 Dec 2023ج.م18.6bج.م17.0bج.م2.2b7.6x8.3x1.1x
Tue, 21 Nov 2023ج.م17.4bج.م16.3bج.م2.2b7.4x8.1x1.1x
Thu, 19 Oct 2023ج.م14.4bج.م15.4bج.م1.9b5.4x7.4x0.9x
Sat, 16 Sep 2023ج.م14.5bج.م15.9bج.م2.0b7.1x7.1x0.9x
Mon, 14 Aug 2023ج.م13.5bج.م15.7bج.م2.1b7.5x6.5x0.9x
Wed, 12 Jul 2023ج.م13.5bج.م15.6bج.م2.1b6.9x6.4x0.9x
Fri, 09 Jun 2023ج.م13.9bج.م16.1bج.م2.2b5.4x6.3x0.9x
Sun, 07 May 2023ج.م14.0bج.م16.2bج.م2.4b5.1x5.9x0.9x
Tue, 04 Apr 2023ج.م14.1bج.م15.7bج.م2.3b5.2x6.1x0.9x
Thu, 02 Mar 2023ج.م14.4bج.م15.7bج.م2.3b5.3x6.3x0.9x
Sat, 28 Jan 2023ج.م15.2bج.م15.6bج.م2.3b5.4x6.7x1x
Mon, 26 Dec 2022ج.م15.0bج.م15.6bج.م2.3b5.3x6.6x1x
Wed, 23 Nov 2022ج.م12.9bج.م15.1bج.م2.2b4.4x5.9x0.9x
Fri, 21 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Sun, 18 Sep 2022ج.م12.9bج.م14.3bج.م2.0b6.1x6.3x0.9x
Tue, 16 Aug 2022ج.م12.7bج.م14.2bج.م2.0b5.5x6.4x0.9x
Thu, 14 Jul 2022ج.م11.8bج.م14.1bج.م1.9b5.6x6.1x0.8x
Sat, 11 Jun 2022ج.م12.2bج.م13.8bج.م1.9b5.9x6.5x0.9x
Price to Earnings Ratio

6.5x


Total Market Cap: ج.م12.2bTotal Earnings: ج.م1.9bTotal Revenue: ج.م13.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 8x202320242025
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 10.9x which is higher than its 3-year average PE of 8.0x.
  • The 3-year average PS ratio of 0.97x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market0.33%
Healthcare-0.28%
Pharma-0.53%
Pharma-0.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SIPC Sabaa International Company for Pharmaceutical and Chemical Industryج.م1.6125.8%
+ج.م82.5m
136.8%PS25.9x
BIOC GlaxoSmithKlineEج.م40.422.0%
+ج.م65.1m
41.8%PE13.9x
NIPH EI- Nile for Pharmaceuticals and Chemical Industriesج.م52.9912.6%
+ج.م60.1m
-22.9%PE5.8x
OCPH October PharmaEج.م115.162.3%
+ج.م31.0m
15.2%PE10.5x
ADCI Arab Drugج.م173.170.4%
+ج.م4.6m
103.7%PE5.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.